Home
Sessions
PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Nonmalignant Disease, Hematologic Malignancies, Palliative Care, and International/Global Oncology
The 5-Year Follow-Up Results of the Efficacy and Safety of Pulse Low-Dose-Rate Radiotherapy (PLDR) Re-Irradiation in Recurrent Nasopharyngeal Carcinoma Patients, A Prospective, Open-Label,Multicenter, Phase II Clinical Trial

Sep 28

PQA 04 - PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Nonmalignant Disease, Hematologic Malignancies, Palliative Care, and International/Global Oncology

2929 - The 5-Year Follow-Up Results of the Efficacy and Safety of Pulse Low-Dose-Rate Radiotherapy (PLDR) Re-Irradiation in Recurrent Nasopharyngeal Carcinoma Patients, A Prospective, Open-Label,Multicenter, Phase II Clinical Trial

03:00pm - 04:00pm ET

Presenter(s)

Peng Zhang, MD - Sichuan Cancer Hospital and Institute, Chengdu, Sichuan